Telo Genomics (Germany) Price Prediction

3D0A Stock  EUR 0.06  0.03  93.44%   
As of 28th of November 2024, The value of RSI of Telo Genomics' share price is at 52. This suggests that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Telo Genomics, making its price go up or down.

Oversold Vs Overbought

52

 
Oversold
 
Overbought
The successful prediction of Telo Genomics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Telo Genomics and does not consider all of the tangible or intangible factors available from Telo Genomics' fundamental data. We analyze noise-free headlines and recent hype associated with Telo Genomics Corp, which may create opportunities for some arbitrage if properly timed.
Using Telo Genomics hype-based prediction, you can estimate the value of Telo Genomics Corp from the perspective of Telo Genomics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Telo Genomics to buy its stock at a price that has no basis in reality. In that case, they are not buying Telo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Telo Genomics after-hype prediction price

    
  EUR 0.03  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Telo Genomics Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
0.000.0329.83
Details
Naive
Forecast
LowNextHigh
0.00050.0229.82
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.020.040.05
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Telo Genomics. Your research has to be compared to or analyzed against Telo Genomics' peers to derive any actionable benefits. When done correctly, Telo Genomics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Telo Genomics Corp.

Telo Genomics After-Hype Price Prediction Density Analysis

As far as predicting the price of Telo Genomics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Telo Genomics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Telo Genomics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Telo Genomics Estimiated After-Hype Price Volatility

In the context of predicting Telo Genomics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Telo Genomics' historical news coverage. Telo Genomics' after-hype downside and upside margins for the prediction period are 0.00 and 29.83, respectively. We have considered Telo Genomics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.06
0.03
After-hype Price
29.83
Upside
Telo Genomics is out of control at this time. Analysis and calculation of next after-hype price of Telo Genomics Corp is based on 3 months time horizon.

Telo Genomics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Telo Genomics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Telo Genomics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Telo Genomics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  3.82 
32.12
 0.00  
 0.00  
0 Events / Month
0 Events / Month
In 5 to 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.06
0.03
1.64 
0.00  
Notes

Telo Genomics Hype Timeline

Telo Genomics Corp is presently traded for 0.06on Frankfurt Exchange of Germany. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Telo is estimated to decline in value after the next headline, with the price expected to drop to 0.03. The average volatility of media hype impact on the company price is insignificant. The price drop on the next news is expected to be -1.64%, whereas the daily expected return is presently at 3.82%. The volatility of related hype on Telo Genomics is about 0.0%, with the expected price after the next announcement by competition of 0.06. The company recorded a loss per share of 0.03. Telo Genomics Corp had not issued any dividends in recent years. The entity had 1:5 split on the 22nd of November 2019. Assuming the 90 days trading horizon the next estimated press release will be in 5 to 10 days.
Check out Telo Genomics Basic Forecasting Models to cross-verify your projections.

Telo Genomics Related Hype Analysis

Having access to credible news sources related to Telo Genomics' direct competition is more important than ever and may enhance your ability to predict Telo Genomics' future price movements. Getting to know how Telo Genomics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Telo Genomics may potentially react to the hype associated with one of its peers.

Telo Genomics Additional Predictive Modules

Most predictive techniques to examine Telo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Telo using various technical indicators. When you analyze Telo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Telo Genomics Predictive Indicators

The successful prediction of Telo Genomics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Telo Genomics Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Telo Genomics based on analysis of Telo Genomics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Telo Genomics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Telo Genomics's related companies.

Story Coverage note for Telo Genomics

The number of cover stories for Telo Genomics depends on current market conditions and Telo Genomics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Telo Genomics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Telo Genomics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Telo Genomics Short Properties

Telo Genomics' future price predictability will typically decrease when Telo Genomics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Telo Genomics Corp often depends not only on the future outlook of the potential Telo Genomics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Telo Genomics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding59.4 M
Shares Float53.6 M

Complementary Tools for Telo Stock analysis

When running Telo Genomics' price analysis, check to measure Telo Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telo Genomics is operating at the current time. Most of Telo Genomics' value examination focuses on studying past and present price action to predict the probability of Telo Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telo Genomics' price. Additionally, you may evaluate how the addition of Telo Genomics to your portfolios can decrease your overall portfolio volatility.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules